Antagonistic peptides of prostaglandin E2 receptor subtype EP4
Antagonistic peptides of prostaglandin E2 receptor subtype EP4 and their use in the treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided herein....
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ABRAN DANIEL PERI KRISHNA G MOFFETT SERGE BERGERON ANNIE |
description | Antagonistic peptides of prostaglandin E2 receptor subtype EP4 and their use in the treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided herein. The antagonistic peptides of the present invention can include the following formula: X-A-RnYm wherein "X" is a hydrogen atom or an amine protecting group producing a carbamate or an amide when reacting with the amine; "A" is L-(4,4')-biphenylalanine or D-(4,4')-biphenylalanine; "R" is an amino acid selected from the group consisting of threonine, serine, tyrosine, glutamic acid, alanine, leucine and glycine; "Y" is lysine; "n" is an integer ranging from 5 to 7; and "m" is an integer ranging from 0 to 2. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US7414029B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US7414029B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US7414029B23</originalsourceid><addsrcrecordid>eNrjZLBzzCtJTM_PyywuyUxWKEgtKMlMSS1WyE9TKCjKLwZK5STmpWTmKbgaKRSlJgOl84sUikuTSioLUhVcA0x4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8aLC5iaGJgZGlk5ExEUoA9AYwCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antagonistic peptides of prostaglandin E2 receptor subtype EP4</title><source>esp@cenet</source><creator>ABRAN DANIEL ; PERI KRISHNA G ; MOFFETT SERGE ; BERGERON ANNIE</creator><creatorcontrib>ABRAN DANIEL ; PERI KRISHNA G ; MOFFETT SERGE ; BERGERON ANNIE</creatorcontrib><description>Antagonistic peptides of prostaglandin E2 receptor subtype EP4 and their use in the treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided herein. The antagonistic peptides of the present invention can include the following formula: X-A-<img id="PRIVATE-USE-CHARACTER-00001" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenopenst.TIF" alt="private use character Parenopenst" img-content="character" img-format="tif" />R<img id="PRIVATE-USE-CHARACTER-00002" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenclosest.TIF" alt="private use character Parenclosest" img-content="character" img-format="tif" />nYm wherein "X" is a hydrogen atom or an amine protecting group producing a carbamate or an amide when reacting with the amine; "A" is L-(4,4')-biphenylalanine or D-(4,4')-biphenylalanine; "R" is an amino acid selected from the group consisting of threonine, serine, tyrosine, glutamic acid, alanine, leucine and glycine; "Y" is lysine; "n" is an integer ranging from 5 to 7; and "m" is an integer ranging from 0 to 2.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080819&DB=EPODOC&CC=US&NR=7414029B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080819&DB=EPODOC&CC=US&NR=7414029B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ABRAN DANIEL</creatorcontrib><creatorcontrib>PERI KRISHNA G</creatorcontrib><creatorcontrib>MOFFETT SERGE</creatorcontrib><creatorcontrib>BERGERON ANNIE</creatorcontrib><title>Antagonistic peptides of prostaglandin E2 receptor subtype EP4</title><description>Antagonistic peptides of prostaglandin E2 receptor subtype EP4 and their use in the treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided herein. The antagonistic peptides of the present invention can include the following formula: X-A-<img id="PRIVATE-USE-CHARACTER-00001" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenopenst.TIF" alt="private use character Parenopenst" img-content="character" img-format="tif" />R<img id="PRIVATE-USE-CHARACTER-00002" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenclosest.TIF" alt="private use character Parenclosest" img-content="character" img-format="tif" />nYm wherein "X" is a hydrogen atom or an amine protecting group producing a carbamate or an amide when reacting with the amine; "A" is L-(4,4')-biphenylalanine or D-(4,4')-biphenylalanine; "R" is an amino acid selected from the group consisting of threonine, serine, tyrosine, glutamic acid, alanine, leucine and glycine; "Y" is lysine; "n" is an integer ranging from 5 to 7; and "m" is an integer ranging from 0 to 2.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBzzCtJTM_PyywuyUxWKEgtKMlMSS1WyE9TKCjKLwZK5STmpWTmKbgaKRSlJgOl84sUikuTSioLUhVcA0x4GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakl8aLC5iaGJgZGlk5ExEUoA9AYwCg</recordid><startdate>20080819</startdate><enddate>20080819</enddate><creator>ABRAN DANIEL</creator><creator>PERI KRISHNA G</creator><creator>MOFFETT SERGE</creator><creator>BERGERON ANNIE</creator><scope>EVB</scope></search><sort><creationdate>20080819</creationdate><title>Antagonistic peptides of prostaglandin E2 receptor subtype EP4</title><author>ABRAN DANIEL ; PERI KRISHNA G ; MOFFETT SERGE ; BERGERON ANNIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US7414029B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ABRAN DANIEL</creatorcontrib><creatorcontrib>PERI KRISHNA G</creatorcontrib><creatorcontrib>MOFFETT SERGE</creatorcontrib><creatorcontrib>BERGERON ANNIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ABRAN DANIEL</au><au>PERI KRISHNA G</au><au>MOFFETT SERGE</au><au>BERGERON ANNIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antagonistic peptides of prostaglandin E2 receptor subtype EP4</title><date>2008-08-19</date><risdate>2008</risdate><abstract>Antagonistic peptides of prostaglandin E2 receptor subtype EP4 and their use in the treatment or prevention of medical conditions associated with oligouric nephropathy, bone resorption, abnormal intestinal crypt cell proliferation or patency of the ductus arteriosus and the like are provided herein. The antagonistic peptides of the present invention can include the following formula: X-A-<img id="PRIVATE-USE-CHARACTER-00001" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenopenst.TIF" alt="private use character Parenopenst" img-content="character" img-format="tif" />R<img id="PRIVATE-USE-CHARACTER-00002" he="7.20mm" wi="8.47mm" file="US07414029-20080819-Parenclosest.TIF" alt="private use character Parenclosest" img-content="character" img-format="tif" />nYm wherein "X" is a hydrogen atom or an amine protecting group producing a carbamate or an amide when reacting with the amine; "A" is L-(4,4')-biphenylalanine or D-(4,4')-biphenylalanine; "R" is an amino acid selected from the group consisting of threonine, serine, tyrosine, glutamic acid, alanine, leucine and glycine; "Y" is lysine; "n" is an integer ranging from 5 to 7; and "m" is an integer ranging from 0 to 2.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US7414029B2 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T22%3A26%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ABRAN%20DANIEL&rft.date=2008-08-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS7414029B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |